Dr. Matthies joined eFFECTOR as Vice President of Corporate Development in November of 2016. In her role, she is responsible for the company’s partnership development and new product planning.
Prior to joining eFFECTOR, Dr. Matthies was Senior Director of Corporate Development at Receptos Inc. where she played an integral role in the IPO, follow-on offerings, and technology platform partnerships. Additionally, Dr. Matthies oversaw new product planning for the company’s lead asset and early stage pipeline. Prior to Receptos, Dr. Matthies held positions of increasing responsibility in corporate development and new product planning at Facet Biotech, Abbott Laboratories through the acquisition of Facet Biotech, and Biogen Idec. She began her career as a strategy consultant in the Life Sciences practice of L.E.K. Consulting.
Dr. Matthies was a postdoctoral fellow in bioengineering at ETH Zurich and completed her Ph.D. in Immunology and Microbiology at Loyola University in Chicago IL. She received her B.A., cum laude, in Biology from Augustana College.